ABT vs DXCM
Abbott Laboratories · DexCom, Inc.
Relative return (rebased to 100)
Key stats
| Metric | ABT | DXCM |
|---|---|---|
| Price | $114.43 | $89.88 |
| Market Cap | $199.32B | $34.68B |
| P/E | 30.55 | 41.47 |
| P/B | 3.83 | 11.73 |
| P/S | 4.50 | 7.44 |
| ROE | 12.5% | 28.3% |
| Net Margin | 14.7% | 17.9% |
| Gross Margin | — | 60.1% |
| Revenue Growth | 5.7% | 15.6% |
| Dividend Yield | 2.10% | — |
| EPS | $3.75 | $2.17 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.